Recent research View all research
About Immutep Limited
Prima BioMed Ltd (PRR) is a global biotechnology company headquartered in Australia. PRR focuses on personalised bio-therapeutic products for cancer. Its lead product is CVac, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients who are in remission. PRR also develops an oral vaccine against Human Papilloma Virus (HPV).
Forsyth Barr Analyst
Share price performance
All stock prices and news delayed 20 minutes
11:25 December 19th 2018 NZDT
Most recent trades All trades for the day
Latest Immutep Limited research
Latest Immutep Limited news
There is currently no news available.